Andrew Lyons
Family · Green Valley, AZNPI 1982001905
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 378 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 378 payments — averaging $18.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Corium, LLC$695
- Almatica Pharma LLC$618
- Otsuka America Pharmaceutical, Inc.$583
- Neurocrine Biosciences, Inc.$552
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$452
- plus $3K from 20 others
What the payments were for
- Food & beverage$6,969100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 92 | $1,188 |
| Corium, LLC | 39 | $695 |
| Almatica Pharma LLC | 27 | $618 |
| Otsuka America Pharmaceutical, Inc. | 28 | $583 |
| Neurocrine Biosciences, Inc. | 28 | $552 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 22 | $452 |
| Ironshore Pharmaceuticals Inc. | 22 | $396 |
| Alkermes, Inc. | 16 | $385 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $320 |
| Lundbeck LLC | 16 | $282 |
| Tris Pharma Inc | 13 | $254 |
| Vanda Pharmaceuticals Inc. | 9 | $243 |
| Johnson & Johnson | 9 | $184 |
| Supernus Pharmaceuticals, Inc. | 8 | $176 |
| Bausch Health US, LLC | 7 | $118 |
| Eisai Inc. | 5 | $86 |
| Vertical Pharmaceuticals, LLC | 3 | $77 |
| Noven Therapeutics, LLC | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Idorsia Pharmaceuticals US Inc | 2 | $28 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Tempus AI, Inc | 1 | $18 |
| Livanova USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$245
How this compares
$6,969 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 19 | $738 |
| Lamotrigine | 19 | $503 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $373 |
| Trazodone Hcl | 40 | $355 |
| Escitalopram Oxalate | 27 | $267 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $260 |
| Duloxetine Hcl | 12 | $191 |
| Sertraline Hcl | 29 | $157 |
| Propranolol Hcl | 18 | $118 |
| Fluoxetine Hcl | 23 | $66 |
| Zolpidem Tartrate | 13 | $54 |
| Clonidine Hcl | 29 | $53 |
| Clonazepam | 13 | $47 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $618 | $15729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,119 family providers in Arizona.
Other family in Green Valley
- Sharon MagalonaMesa$441K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Rebecca McCollaumMesa$149K
- Lindsay CarterTucson$108K
- Audrey StevensonPhoenix$83K
- Celeste FineGilbert$82K
- Mia ChorneyChandler$79K
- Jennifer PrinceScottsdale$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.